Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX)

9 filings reported holding EVAX - Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share as of Q1 2025.
Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.21M shares of 316M outstanding shares and own 0.38% of the company stock.
Largest 9 shareholders include Merck & Co., Inc. (1.21M shares), RHUMBLINE ADVISERS (2 shares), JPMORGAN CHASE & CO (0 shares), SouthState Corp (0 shares), Catalina Capital Group, LLC (0 shares), ARMISTICE CAPITAL, LLC (0 shares), MILLENNIUM MANAGEMENT LLC (0 shares), Invst, LLC (0 shares), and Beacon Capital Management, LLC (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.